Management of Anxiety and Panic in Elderly with Mild Dementia

Assessment and Screening

The American Geriatrics Society recommends using validated screening tools, such as the Penn State Worry Questionnaire-Abbreviated (PSWQ-A) with a cut-off score of 17, to detect significant anxiety in mild dementia 2, 3
The Alzheimer's Association suggests using the Geriatric Anxiety Inventory (GAI) with a cut-off score of 8 for detecting significant anxiety in mild dementia 2, 3
Screening for co-occurring depression using the PHQ-9 or Geriatric Depression Scale is recommended, as depression frequently co-occurs with anxiety in dementia 2, 3, 1

The American College of Physicians recommends implementing behavioral and environmental modifications as the primary treatment approach, including applying the "three R's" technique, modifying the environment, and providing caregiver education 1
Regular physical exercise, such as aerobic, resistance, and balance exercises, is beneficial for both dementia and anxiety symptoms 8, 6, 7
Structured, tailored activities aligned with the patient's current capabilities and previous interests can help reduce anxiety symptoms 5

The American Psychiatric Association recommends starting with low doses of SSRIs, such as citalopram or sertraline, and gradually titrating upward to therapeutic range over several weeks 1
SSRIs are preferred due to their minimal anticholinergic effects and better safety profile in elderly patients 1
Benzodiazepines should be reserved for severe, acute panic episodes and used with extreme caution due to significant risks, including cognitive impairment worsening, increased fall risk, and paradoxical agitation 1, 9

Antipsychotics, typical and atypical, should be avoided due to the FDA black box warning for increased mortality risk in dementia patients 1
Anticholinergic medications should be avoided as they worsen cognition and increase confusion 7, 1
Long-acting benzodiazepines should be avoided due to accumulation and increased adverse effects 1

Reassessing anxiety symptoms at 4-6 weeks using the same validated screening tools is recommended 1
Monitoring for treatment-emergent side effects, particularly cognitive worsening, falls, or behavioral changes, is crucial 1
Evaluating caregiver burden and distress as part of ongoing management is important 4, 7